Chronic renal comorbidities in pyoderma gangrenosum: a retrospective cohort study.

Authors:
Kridin K; Solomon A; Britva RL; Bitan DT; Cohen AD.

Journal:
Immunol Res

Publication Year: 2021

DOI:
10.1007/s12026-021-09187-3

PMCID:
PMC8266709

PMID:
33890227

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Immunol Res

Abbreviation: Immunol Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Autoinflammatory diseases and the kidney.
Hegazy MT; Fayed A; Nuzzolese R and 2 more (2023) - Transparency Score: 3/6
Circulating anti-hypothalamus antibodies in celiac patients: tissue transglutaminase friend or foe?
Iervasi E; Strangio A; Greco L and 2 more (2023) - Transparency Score: 3/6
COVID-19 vaccine-associated myositis: a comprehensive review of the literature driven by a case rep…
Syrmou V; Liaskos C; Ntavari N and 6 more (2023) - Transparency Score: 3/6
COVID-19 vaccines adverse events: potential molecular mechanisms.
Lamprinou M; Sachinidis A; Stamoula E and 2 more (2023) - Transparency Score: 2/6
Efficacy and safety of IL-23 inhibitors in the treatment of psoriatic arthritis: a meta-analysis ba…
Huang X; Shentu H; He Y and 4 more (2023) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestADC served as an advisor, investigator, or speaker for Abbvie, BI, Dexcel Pharma, Janssen, Novartis, Perrigo, Pfizer, and Rafa. None of the other authors has any conflicts of interest to declare. Conflict of interest ADC served as an advisor, investigator, or speaker for Abbvie, BI, Dexcel Pharma, Janssen, Novartis, Perrigo, Pfizer, and Rafa. None of the other authors has any conflicts of interest to declare."

Evidence found in paper:

"Funding Open Access funding enabled and organized by Projekt DEAL."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025